A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and conferred improved outcomes and insulin independence at 1 year in a small study of ...

Is it a smart investment or just another fad? See what happened when I used it and what other users are saying!

The gut microbiome, a vast assortment of bacteria and other microorganisms that inhabit our digestive system, plays a ...

Eolo Pharma, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, today announced the publication of its first-in-human study in Nature Metabolism, ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

The first patient has been dosed with mRNA-4106, a novel pantumor antigen therapy candidate, in a phase 1 trial (NCT06880549) for those with advanced or metastatic solid tumors. 1 In the open-label, ...

Demonstrated strong safety and favorable pharmacokinetics in Phase 1 study A First-in-class oral small molecule modulating immune cell metabolism via glycogen phosphorylase inhibition Once-daily ...

Demonstrated strong safety and favorable pharmacokinetics in Phase 1 study A First-in-class oral small molecule modulating immune cell metabolism via glycogen phosphorylase inhibition Once-daily oral ...

The Phase 1 study presented this week at Digestive Disease Week taking place in San Diego, California evaluated the pharmacokinetics and metabolism of a single dose of TH104 (16 mg buccal film ...